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ARTICLE
Global rewiring of cellular metabolism renders
Saccharomyces cerevisiae Crabtree negative
Zongjie Dai1,2, Mingtao Huang1,2, Yun Chen1,2, Verena Siewers1,2 & Jens Nielsen 1,2,3,4
Saccharomyces cerevisiae is a Crabtree-positive eukaryal model organism. It is believed that
the Crabtree effect has evolved as a competition mechanism by allowing for rapid growth and
production of ethanol at aerobic glucose excess conditions. This inherent property of yeast
metabolism and the multiple mechanisms underlying it require a global rewiring of the entire
metabolic network to abolish the Crabtree effect. Through rational engineering of pyruvate
metabolism combined with adaptive laboratory evolution (ALE), we demonstrate that it is
possible to obtain such a global rewiring and hereby turn S. cerevisiae into a Crabtree-negative
yeast. Using integrated systems biology analysis, we identify that the global rewiring of
cellular metabolism is accomplished through a mutation in the RNA polymerase II mediator
complex, which is also observed in cancer cells expressing the Warburg effect.
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The yeast Saccharomyces cerevisiae is a widely used modelorganism for studying the biology of eukaryal cells as wellas it is extensively used as a cell factory for the production
of pharmaceuticals, chemicals, and biofuels1,2. Its metabolism has
evolved to have oxidative fermentation, meaning that even in the
presence of oxygen, the yeast uses fermentative metabolism when
glucose is in excess, a metabolic feature that is generally referred
to as the Crabtree effect3,4. This million-year-old evolution fea-
ture ensures the advant.age in its ecological niche due to the
ability to rapidly consume glucose and produce ethanol that has
antiseptic properties. However, it generally results in reduced
yields when this yeast is used as a cell factory. There is therefore
much interest in rewiring the central carbon metabolism to
abolish the Crabtree effect.
Eliminating pyruvate decarboxylase activity in yeast com-
pletely abolishes the Crabtree effect, but the growth deﬁciency
of pyruvate decarboxylase minus (Pdc−) strains in excess
glucose conditions5 limits their application for biotechnology.
Even though Pdc− strains have been studied for last 25 years,
only one strategy has so far enabled successful restoration of
the growth of Pdc− strains in a minimal medium with excess
glucose. This strategy involves introducing MTH1 mutations,
which were originally identiﬁed from Pdc− strains evolved to
grow in excess glucose6. However, the speciﬁc growth rate of
this strain was only at 0.1 h−1, and acetyl-CoA generation in
the cytosol relies on acetate supplementation and the native
ATP-dependent acetyl-CoA synthetase7.
To overcome this challenge, we create an alternative pyruvate
dehydrogenase (PDH) bypass in S. cerevisiae with an ATP-
independent acetyl-CoA synthesis pathway. With this, growth of
a Pdc− strain is successfully restored in minimal media with excess
glucose. Combining rational design, adaptive laboratory evolution
(ALE), and reverse engineering, the speciﬁc growth rate of the best
strain reaches 0.218 h−1, which is close to the maximum growth of
S. cerevisiae with purely respiratory metabolism8 and the maximum
speciﬁc growth rate of most Crabtree-negative yeasts9. We ﬁnd that,
to unlock the millions of years of evolution that has determined
metabolic features of S. cerevisiae, many different metabolic parts
need to be engineered, and an important element is enabling global
transcriptional alteration by having a mutation in the mediator
complex that supports rewiring of cellular metabolism.
Results
Establishing a functional ethanol overﬂow negative yeast. In S.
cerevisiae, deletion of PDC1, 5, and 6 completely abolishes ethanol
production. However, pyruvate decarboxylase is also an indis-
pensable enzyme of the PDH bypass, which provides cytosolic
acetyl-CoA required for lipid biosynthesis and hereby, for cell
growth in a sugar-based media (Fig. 1a). This is the main reason
for Pdc− strains being growth deﬁcient in the glucose media.
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Fig. 1 Establishment of a cytosolic acetyl-CoA synthetic pathway in Pdc− S. cerevisiae. a The native and alternative cytosolic acetyl-CoA synthetic pathway
in S. cerevisiae. The native metabolic network (yellow background) converts pyruvate to acetyl-CoA by pyruvate decarboxylase (Pdc1, 5, and 6),
acetaldehyde dehydrogenase (Ald2, 3, 4, 5, and 6), and acetyl-CoA synthetase (Acs1 and 2). The metabolic network (green background) converts pyruvate
to acetyl-CoA by pyruvate oxidase (PO) and phosphotransacetylase (PTA). b Growth curve of a Pdc− yeast strain carrying different PO/PTA plasmids in a
synthetic medium containing 20 g l−1 glucose. sp: S. pneumoniae, lp: L. plantarum, av: A. viridans, se: S. enterica. c Growth and metabolite proﬁles of sZJD-11
(acs2Δ::POav acs1Δ::PTAse) in 20 g l−1 glucose minimal medium. d Acetyl-CoA-derived farnesene and 3-hydroxypropanoate (3-HP) production in wild-type
strain CEN.PK113-11C (orange bar) and sZJD-11 (blue bar) background strains. e Growth and metabolite proﬁles of sZJD-23 (acs2Δ::POav acs1Δ::PTAse
gpp1Δ gpp2Δ) in 20 g l−1 glucose minimal medium. All data represent the mean ± s.d. of biological triplicates
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05409-9
2 NATURE COMMUNICATIONS |  (2018) 9:3059 | DOI: 10.1038/s41467-018-05409-9 | www.nature.com/naturecommunications
To restore growth of a Pdc− strain in excess glucose media, we
established an ATP-independent cytosolic acetyl-CoA producing
pathway (Fig. 1a) in a Pdc− S. cerevisiae strain, which enabled
growth in an excess glucose medium (Fig. 1b and Supplementary
Figure 1). In this pathway, pyruvate oxidase (PO, EC 1.2.3.3)
from Aerococcus viridans (av) catalyzes the decarboxylation of
pyruvate to acetyl-phosphate, and subsequently, phosphotransa-
cetylase (PTA, EC 2.3.1.8) from Salmonella enterica (se) converts
acetyl-phosphate to acetyl-CoA (Fig. 1a), which was conﬁrmed by
the enzyme activity measurements (Supplementary Figure 2). To
further verify the capacity of this pathway, the native acetyl-CoA
synthetases, Acs1 and Acs2, were replaced by PTAse and POav,
respectively, resulting in strain sZJD-11 (Supplementary Table 1),
with a speciﬁc growth rate of 0.086 h−1. The production of acetyl-
CoA-derived chemicals farnesene (20.5 mg l−1) and 3-
hydroxypropionate (61.4 mg l−1) in the sZJD-11 background
strain (Fig. 1d) further demonstrated that this pathway is able to
deliver cytosolic acetyl-CoA, even for heterologous pathways. To
reduce acetate accumulation in sZJD-11 (Fig. 1c), glycerol 3-
phosphate phosphatase (GPP) was identiﬁed as a promiscuous
enzyme converting acetyl-phosphate into acetate (Supplementary
Figure 3). The GPP1 and GPP2 double-deletion strain sZJD-23
accumulated less than 0.67 g l−1 acetate in the culture medium, a
decrease by 67.2% compared with sZJD-11. Other extracellular
metabolites (pyruvate, succinate, and glycerol) were also pro-
duced at much lower levels than by sZJD-11. The speciﬁc growth
rate of this strain reached 0.109 h−1, which represents a 26.7%
increase compared with sZJD-11 (Fig. 1e, c).
Increasing growth of the Crabtree-negative S. cerevisiae.
Although the speciﬁc growth rate of this S. cerevisiae strain is
similar to that of some natural Crabtree-negative yeasts, such as
Kluyveromyces nonfermentans (0.101 h−1) and Eremothecium
sinecaudum (0.117–0.122 h−1), it is still much lower than for
most natural Crabtree-negative yeasts (0.249–0.429 h−1) (Sup-
plementary Table 2).
We therefore established three independent yeast populations
based on exposing sZJD-24 (prototrophic strain based on sZJD-
23) (Supplementary Table 1) to ALE for 40 days, which is a
duration compromising the selection of clones with improved
ﬁtness and not accumulating too many mutations. All of the three
evolved populations have a higher speciﬁc growth rate compared
with starting strain sZJD-24. (Supplementary Figure 4). The
maximum speciﬁc growth rate of clones picked from each of these
three populations reached 0.217 h−1, 0.221 h−1, and 0.209 h−1,
respectively (Fig. 2a). Through genome sequencing of seven clones
(two each from sZJD-24A and sZJD-24B, three from sZJD-24C),
we found a total of 19 single nucleotide variations (SNVs) in 18
genes (Supplementary Table 3). Although there were no shared
mutations among all seven clones (Fig. 2b), a nonstop mutation in
MED2 was identiﬁed in ﬁve clones derived from lines sZJD-24A
and sZJD-24C. The two clones of line sZJD-24B shared a mutation
in MED3. Both Med2 and Med3 are components of the tail
module of the RNA polymerase II mediator complex10. These
results indicated that the mediator complex may play a key role in
regulating cell growth. Only three SNVs were identiﬁed in the
clones from line sZJD-24C, which shared a nonsense mutation in
GPD1 encoding a NADH-dependent glycerol-3-phosphate dehy-
drogenase11. For all clones in line sZJD-24B, besides MED3, we
found shared mutations in SIW14 and MHO1. Siw14 is tyrosine
phosphatase involved in actin organization and endocytosis12,
Mho1 is a protein of unknown function.
Therefore, MED2, MED3, GPD1, HXK2, and SIW14 were
chosen as reverse engineering targets to evaluate if mutations in
these gene were causal. We successfully obtained the GPD1W71*
and MED2*432Y single mutant strains sZJD-26 and sZJD-27,
respectively, using the Cas9-expressing strain sZJD-25. The
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Fig. 2 Characterization of adaptive laboratory evolution strains and reverse engineered strains. a Determination of the speciﬁc growth rate of evolved lines
(sZJD-24A, sZJD-24B, and sZJD-24C) isolated at the end of the evolutionary experiment in 20 g l−1 glucose minimal medium. b The genes with mutations
identiﬁed in all of the isolated strains. sZJD-24A1 and A2 were from lines sZJD-24A, sZJD-24B1; B2 was from lines sZJD-24B, sZJD24C1; C2 and C3 were
from line sZJD-24C. c Determination of the speciﬁc growth rate of reverse engineered strains based on sZJD-23 in shake ﬂasks. d Growth and metabolite
proﬁles of sZJD-28 in 20 g l−1 glucose minimal medium. All data represent the mean ± s.d. of biological triplicates
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speciﬁc growth rate of these two strains increased by 31.5 and
47.0% compared with the starting strain sZJD-25, reaching
0.139 h−1, and 0.156 h−1 respectively. A MED2*432Y and
GPD1W71* double-mutant strain sZJD-28 reached an even higher
speciﬁc growth rate of 0.205 h−1, which is 98% of the speciﬁc
growth rate of the evolved line sZJD-24C (Fig. 2c), showing a
clear causal effect of these two mutations. This is consistent with
the ﬁnding that these two mutations were the only two SNVs
found in the evolved strains sZJD-24C2 and sZJD-24C3 (Fig. 2b).
sZJD-28 consumed glucose with faster rate and reached higher
OD600 value compared with starting strain sZJD-23. The
extracellular metabolites were also lower than those of sZJD-23
(Figs. 2d, 1e). Compared with wild-type strain CEN.PK113-11c,
sZJD-28 had much higher biomass yield and lower RQ value,
which is close to 1. The maximal speciﬁc growth rate of sZJD-28
reached 0.218 h−1 (Table 1). Thus, through identiﬁcation of
targets using ALE, we managed to engineer a better and faster
growing Crabtree-negative S. cerevisiae with reduced carbon loss.
Transcriptional proﬁles of the Crabtree-negative strain. To
understand the underlying mechanism of how the mutations
results in faster growth rate of the reverse engineered strains, we
used RNA-Seq to perform transcriptome analysis of the parental
strain sZJD-25 and the three strains sZJD-26, sZJD-27, and sZJD-
28.
Transcriptome analysis showed that in sZJD-28, totally, 2096
genes, about 33% of all genes of S. cerevisiae, were signiﬁcantly
(padj < 0.01) differentially expressed and 1562 genes in sZJD-27
compared with sZJD-25 (Fig. 3a). This indicated that the nonstop
mutation of MED2 resulted in a global impact on the metabolic
network. Med2 is one of the subunits of the tail module10, which
is one of the four parts of the mediator complex, and it is required
for the regulated transcription of nearly all RNA polymerase II-
dependent genes in S. cerevisiae13–15. The tail module mediates
mediator complex-associated transcriptional regulation on
SAGA-regulated, TATA-containing genes which account for
about 15% of all the genes in yeast16,17 (Supplementary Figure 5).
Indeed, almost half of all TATA-containing genes had signiﬁ-
cantly altered expression in the MED2 mutant strains sZJD-28
(7.5%) and sZJD-27 (6.8%) (Fig. 3b). It indicated a clear causal
effect of this mutation. Additionally, the expession level of
TATA-containing genes in the MED2 mutant strain were
predominantly downregulated, especially in the double-mutant
strain sZJD-28 (Fig. 3c), which is clearly seen in the Volcano plot
of sZJD-28 (Supplementary Figure 6). GO Slim Mapper analysis
on the 114 shared TATA-containing genes showed that GO terms
related to response to cellular amino acid metabolic processes,
carbon metabolism, and chemical and oxidative stress were
enriched (Supplementary Data 1). It indicated that altering the
expression of genes with these GO terms may play an
indispensable role in improving the cell growth rate.
The reporter GO term analysis showed that genes associated
with GO terms related to translation are upregulated (upper part
of heat map in Fig. 3d), whereas genes associated with GO terms
related to carbon metabolism are downregulated (lower part of
heat map in Fig. 3d). Protein synthesis is required for cell growth
and needs ribosomes to polymerize amino acids into polypeptide
chains. The cellular growth rate is linearly correlated with
ribosome abundance, and the expression of ribosome-associated
genes, including genes coding for ribosomal proteins and rRNA
biogenesis, therefore affects the growth rate18,19. Indeed, in sZJD-
28 and sZJD-27, protein synthesis-associated genes were
signiﬁcantly upregulated (Fig. 3d and Supplementary Figure 7).
In addition, reporter TFs analysis showed that genes controlled by
chromatin remodeling-related TFs such as Snf2, Snf6, Sin3, Sas3,
and Rsc1 were signiﬁcantly changed in sZJD-27 and sZJD-28, in
contrast to sZJD-25 (Supplementary Figure 8-9). It suggested that
gene transcription may have become more active, supporting
increased protein synthesis in these two strains. However,
increasing the ribosomal protein fraction would reduce the
fraction of metabolic proteins20. Indeed, GO terms related to
carbon metabolism-contained genes were signiﬁcantly down-
regulated in sZJD-27 and sZJD-28 (Fig. 3d and Supplementary
Figure 7). Downregulating of these metabolic genes would save
the resource for ribosomal proteins synthesis, as glycolytic
enzymes account for a major fraction of the cellular proteome.
These results suggested that the introduced mutations led to
redistributed and active protein synthesis, which may support a
faster cell growth rate.
Disscusion
Pdc− S. cerevisiae strains cannot grow in batch cultures on syn-
thetic glucose medium. Two reasons are lacking of cytosolic
acetyl-CoA supply and limited capacity of reoxidation of cytosolic
NADH21. In sZJD-25, the PO/PTA pathway can produce acetyl-
CoA in the cytosol, which supported the growth of Pdc− S. cer-
evisiae strains in an excess glucose medium. However, the reox-
idation of cytosolic NADH still mainly relies on the
mitochondrial respiratory chain due to the absence of alcoholic
fermentation. In sZJD-25, the unrestricted glucose uptake and
high glycolytic activity would particularly cause problems with
recycling of cytosolic NADH to NAD+. Compared with sZJD-25,
the high-afﬁnity glucose transporter genes HXT2, HXT4, HXT6,
HXT7, HXT10, and HXT14 were upregulated and the low/med-
ium-afﬁnity glucose transporter genes HXT1, HXT3, HXT5,
HXT9, and HXT11 were downregulated in sZJD-28. (Fig. 3e). The
fold changes of high-afﬁnity glucose transporter genes were
higher than that of the low-afﬁnity ones (Supplementary
Table 1 Physiological parameters of the wild-type and engineered strainsa
Parameter CEN.PK113-11c sZJD-25 sZJD-28
μ (h−1) 0.374 ± 0.013 0.140 ± 0.003 0.218 ± 0.006
Ybiomass (g g−1) 0.126 ± 0.000 0.306 ± 0.003 0.368 ± 0.026
qglu (mmol gDW−1 h−1) −16.405 ± 0.587 −2.284 ± 0.026 −3.255 ± 0.264
qeth (mmol gDW−1 h−1) 23.694 ± 0.485 ND ND
qgly (mmol gDW−1 h−1) 1.964 ± 0.061 ND ND
qace (mmol gDW−1 h−1) 0.361 ± 0.015 0.810 ± 0.017 1.397 ± 0.265
qpyr (mmol gDW−1 h−1) 0.152 ± 0.003 0.026 ± 0.001 0.047 ± 0.014
qCO2 (mmol gDW−1 h−1) 27.461 ± 0.877 5.461 ± 0.043 7.633 ± 0.869
qO2 (mmol gDW−1 h−1) 3.575 ± 0.032 4.319 ± 0.021 6.400 ± 0.704
RQ 7.683 ± 0.314 1.264 ± 0.016 1.192 ± 0.010
aData are shown mean values ± standard deviations of triplicates
ND not detected
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Figure 10). Expression of high-afﬁnity glucose transporters were
repressed by high levels of glucose and induced by low levels of
glucose22. Transriptional changes in these glucose transporters
indicated that glucose uptake was restricted in sZJD-28 compared
with sZJD-25. Additonally, almost all of the genes in glycolysis
were downregulated in sZJD-28 (Fig. 3e). Restricted glucose
uptake and activity of glycolysis would release the burden on the
respiration chain, which is consistent with the the expression
proﬁles of oxidative phosphorylation (OXPHOS) genes, especially
in sZJD-28 NADH dehydrogenase genes (NDE1 and NDE2) and
ubiquinol-cytochrome c oxidoreductase genes (complex III),
which were signiﬁcantly downregulated compared with sZJD-25
(Supplementary Figure 11). These results indicate that the limited
glucose consumption capacity of sZJD-25, which was enhanced
by the introduced mutations led to higher glycolytic ﬂux in sZJD-
28, but now with balancing of NADH formation and oxidation
back to NAD+. The faster glucose consumption rate, higher
biomass yield and lower RQ of sZJD-28 compared with that of
sZJD-25 (Table 1) further conﬁrmed the higher glycolytic ﬂux
and respiration rate in the reverse engineered sZJD-28. The bal-
ance between fermentation and respiration may lead to efﬁcient
carbon and electron ﬂux in the cell, which can support the faster
growth rate.
Taken together, we demonstrated that the Crabtree-positive S.
cerevisiae can be turned into a Crabtree-negative yeast by sys-
tematic engineering, which included rational pathway design and
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Fig. 3 Transcriptional analysis of reverse engineered strains and parental strain. a Venn diagram showing the numbers of signiﬁcantly (padj < 0.01)
regulated genes of reverse engineered strains compared with the parental strain. b Fraction of TATA-containing and TATA-less genes among differentially
regulated genes in sZJD-28, sZJD-27, and sZJD-26. c Box plot of the log2-fold change of the signiﬁcantly (padj < 0.01) regulated genes in sZJD-28, sZJD-
27, and sZJD-26. The bold line in the box represents the median and the yellow dot represents the mean. The lower and upper bounds of the box indicate
the ﬁrst and third quartiles, respectively, and whishers represent ±1.5× the interquartile range (IQR). d Reporter GO term analysis of the transcription
proﬁles of sZJD-28. The color key shows the rank of the GO terms, and the signiﬁcance (p value) of the GO terms is included in each cell of the heatmap.
GO terms that have a consensus rank ≤10 in any of the groups are shown in the heatmap. Dist (dn) is distinct-directional down, Mix (dn) is mixed-
directional down, Nondir is non-directional change, Mix (up) is mix-directional up, and Dist (up) is distinct-directional up. e Transcriptional levels of genes
related to glucose transportation, glycolysis pathway, and TCA cycle in sZJD-28, sZJD-27 and sZJD-26 compared with sZJD-25
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system biology analysis. The growth rate of this engineered S.
cerevisiae reached 0.218 h−1, which was two folds of previous
MTH1 reverse engineered strains and almost reached the level of
many natural Crabtree-negative yeasts. By systems biology ana-
lysis, the mediator complex was identiﬁed as a global regulator
involved in rewiring the central carbon metabolism and allocating
protein synthesis in a way that favors faster growth of this
Crabtree-negative S. cerevisiae. We believe that the derived yeast
strain represents a possible platform strain for use in bio-
technology as well as global rewiring of yeast metabolism through
engineering; the mediator complex may be used as a strategy in
metabolic engineering of yeast. Additionally, our ﬁnding on
restricting glucose ﬂux by modulation of the conservative med-
iator complex may give an insight into cancer metabolism due to
the similarity between Crabtree effect and Warburg effect in
cancer cells23. Thus, many cancer cells have altered pyruvate
metabolism24 and mutations in the mediator complex25,26.
Methods
Strains and plasmids. The yeast S. cerevisiae CEN.PK YMZ-E1, IMI076, and
CEN.PK 113-11C were used as host strain for strain engineering. The strains,
plasmids, and primers used in this study are listed in the Supplementary Tables 1, 4
and Supplementary Data 2, respectively. POav, POsp, POlp, and PTAse (Supple-
mentary Data 2) were codon-optimized for yeast expression and synthesized by
Genscript.
Reagents. Primers were synthesized by Sigma-Aldrich. DNA puriﬁcation and
plasmid extraction kits, Taq DNA polymerase, and restriction enzymes were the
products of ThemoFisher Scientiﬁc. PrimeStar DNA polymerase was purchased
from TaKaRa Bio. For genomic DNA extraction, the Blood & Cell culture DNA Kit
(Qiagen) was used. For RNA extraction, the RNeasy Mini Kit (Qiagen) was used.
All chemicals used were purchased from Sigma-Aldrich, if not otherwise stated.
Culture conditions and media. All S. cerevisiae strains were cultivated at 200 r.p.
m., 30°C. To determine the growth rate, strains were inoculated into the medium
with an initial OD600 of 0.05. YPD or YPE media (10 g l−1 yeast extract, 20 g l−1
peptone, 20 g l−1 glucose or ethanol) were used for preparing competent cells.
Synthetic complete media without uracil (SCD-URA or SCE-URA) were used to
grow strains containing URA3-based plasmids. The media consisted of 6.9 g l−1
yeast nitrogen base (YNB) without amino acids (Formedium), 770mg l−1 complete
supplement mixture (CSM, w/o uracil) (Formedium), and 20 g l−1 glucose or
ethanol. SCD+ 5’-FOA or SCE+ 5’-FOA plates were used to select against the
URA3 marker and which contained 6.9 g l−1 YNB, 770mg l−1 CSM, 0.8 g l−1 5-
ﬂuoroorotic acid, and 20 g l−1 glucose or ethanol. Stains containing a KanMX
cassette were selected on YPD plates containing 200mg l−1 G418. Shake ﬂask batch
fermentation was carried out in minimal medium, pH 6.3, consisting of 7.5 g l−1
(NH4)2SO4, 14.4 g l−1 KH2PO4, 0.5 g l−1 MgSO4·7H2O, 20 g l−1 glucose, trace
metal, and vitamin solution27 supplemented with 40mg l−1 uracil and/or 40 mg l−1
histidine, if needed. For batch fermentation in bioreactors, the methods in previous
work28 were followed. Speciﬁcally, strains were grown in deﬁned minimal medium
containing: 20 g l−1 glucose, 5 g l−1 (NH4)2SO4, 3 g l−1 KH2PO4, 0.5 g l−1
MgSO4.7H2O, 125 µl antifoam 204 (Sigma-Aldrich, USA), 40 mg l−1 uracil,
40 mg l−1 histidine, trace metals solution, and vitamins. Batch fermentations were
performed at 30°C in 1.2 l bioreactors (DasGip, Germany) with a working volume of
500ml. Cultures were operated with 800 r.p.m. agitation and 1vvm gas ﬂow of pure
dried air. Culture pH was maintained at 5.0 by automated addition of 2M KOH or
2M H2SO4. The CO2 and O2 concentrations in the exhaust gas were analyzed real
time with a GA4 gas analyzer (DasGip, Germany). The oxygen uptake rate at each
time point was calculated by correcting for the dilution caused by CO2 production
according to the Eq. 1:
OUR ¼ F ´O2in
22:4
 N2in
N2out
´
F ´O2out
22:4
ð1Þ
where, F is the gas ﬂow existing the bioreactor, O2 in is the fractional concentration
of O2 in the air entering the bioreactor, O2 out is the fractional concentration of O2
in the gas existing the bioreactor, N2in is the combined fractional concentration of
nitrogen and argon in the air entering the bioreactor (0.791) and N2 out is the
combined fractional concentration of nitrogen and argon existing the bioreactor
(1-O2out-CO2out). The total mols of oxygen consumed until each time point were
calculated by integrating the OUR curve against time, and the resulting values were
against the biomass concentration in grams of cell dry weight. The speciﬁc oxygen
consumption rate was calculated by taking the slope of the linear trendline and
multiplying by the growth rate. For CO2 calculation, ﬁrst the release rate was
calculated by Eq. 2:
CER ¼ F ´CO2out
22:4
 F ´CO2in
22:4
ð2Þ
and then, it is the same procedure as for O2.
Genetic manipulation. For plasmid construction, standard procedures of restric-
tion enzyme digestion and ligation were used29. For gene deletion, integration, and
point mutation, two strategies were used in this study. One way is seamless gene
deletion or integration by using Kluyveromyces lactis URA3 (KlURA3) as a selection
marker30. The KlURA3 marker was ﬂanked by two homologous sequences, which
were used for looping out the KlURA3 marker after gene deletion and integrating
via yeast homologous recombination system. Removing the KlURA3 marker from
the strain can be performed by using selective SCD+ 5’-FOA or SCE+ 5’-FOA
plates. The other way for gene deletion, integration, and point mutation is
CRISPR–Cas9-based strategy31. The Cas9 expression cassette was ﬁrst fused with a
KanMX cassette and integrated into X-2 site of the yeast genome for utilization of
CRISPR–Cas9 system. For ALE, URA3 and HIS3 were integrated into XI-5 and X-2
sites of the starting strain sZJD-23, respectively, resulting in strain sZJD-24. All of
the plasmids and gene deletion or integration cassettes were transformed into yeast
strains by using the LiAc/SS DNA/PEG method32.
Metabolite extract and analysis. For HPLC analysis, 1 ml of the fermentation
broth was centrifuged at 18,000 g for 5 min at 4°C. The supernatant was ﬁltered
through a 0.2 μm ﬁlter (VWD) then analyzed on an Aminex HPX-87H column
(Bio-rad) in an Ultimate 3000 HPLC system (ThermoFisher Scientiﬁc). To detect
extracellular glucose, ethanol, glycerol, acetate, pyruvate, and succinate, the column
was set at 45°C and eluted with 5 mM H2SO4 at a ﬂow rate of 0.6 ml min−1. For 3-
HP analysis, the column was set at 60°C and eluted with 1 mM H2SO4 at a ﬂow rate
of 0.6 ml min−1 33. For farnesene analysis, procedures and conditions in the pre-
vious work by Tippmann et al34. were followed. Speciﬁcally, a sample was taken
from the cultivation broth after 72 hours. An aliquot was taken from the dodecane
phase and diluted ﬁve times in hexane for injection in GC-FID. The 2-µl samples
were injected in splitless mode, with injection temperature at 200°C. ZB-50 column
(30 m × 0.25 mm I.D., 0.25 µm ﬁlm thickness; Phenomenex, Torrance, CA, USA),
were used with helium as carrier gas at a ﬂow rate of 1 ml min−1. Initial oven
temperature was set at 50°C for 1.5 min, increased up to 170°C (30°C min−1) and
held for 1.5 min. The temperature was then increased to 300°C (15°C min−1) and
maintained for 3 min.
Enzyme activity assay. For cell extract preparation, yeast cells were harvested
during the exponential phase and washed with cold enzyme activity detection
buffer (1 M potassium phosphate, pH 6.7 and 100 mM Tris HCl, pH 7.4 for pyr-
uvate oxidase and phosphotransacetylase, respectively). Then, the cell suspension
was transferred into 2 ml lysing matrix tubes containing beads (MP Biomedicals).
Cells were lysed by the MP FastPrep-24 instrument with four 20 sec cycles at the
speed of 4.0 m s−1; the cell lysate was cooled down in ice for 5 min between cycles.
Cell debris was removed from the cell lysate by centrifugation at 18,000 g for 5 min
at 4°C, and the supernatant was used for enzyme activity assays. Protein con-
centration was determined using the Quick Start Bradford Protein Assay (Bio-
Rad). For pyruvate oxidase and phosphotransacetylase activity analysis, previously
described methods were used35,36. Speciﬁcally, for pyruvate oxidase, spectro-
photometric stop rate determination method was used. The assay condition was:
37 °C, pH= 6.7, 565 nm, and light path= 1 cm. Reagent A: 1 M potassium phos-
phate buffer, pH 6.7 at 37°C, adjust to pH 6.7 with 1M NaOH; Reagent B: 1 mM
ﬂavin adenine dinucleotide solution, prepare fresh; Reagent C: 10 mM thiamine
pyrophosphate solution, prepare fresh; Reagent D: 15 mM 4-aminoantipyrine
solution; Reagent E: peroxidase enzyme solution containing 50 purpurogallin units
ml−1 in deionized water using peroxidase, immediately before use; Reagent F: 100
mM MgCl2; Reagent G: 0.2% (v/v) N,N-dimethylaniline suspension; Reagent H:
prepare by combining 1 ml of Reagent F and 2 ml of Reagent G, prepare fresh;
Reagent I: 1 M sodium pyruvate solution; Reagent J: 200 mM sodium phosphate
solution; Reagent K: 100 mM citric acid solution; Reagent L: McIlvain Buffer,
prepare 100 ml by adding 63.15 ml of Reagent J and 36.85 ml of Reagent K; Reagent
M: 100 mM ethylenediaminetetraacetic acid solution, adjust to pH 5.5 with either 1
M NaOH or 1M HCl; Reagent N: 10 mM potassium phosphate with 10 μM ﬂavin
adenine dinucleotide solution, pH 7.0. Procedure: prepare a reaction cocktail by
pipetting (in ml) the following reagents into a suitable container: deionized water
1.70, Reagent A 2.00, Reagent B 0.10, Reagent C 0.20, Reagent D 1.00, and Reagent
E 1.00. Mix by swirling and equilibrate to 37°C. Pipette (in ml) the following
reagents into suitable containers (test and blank): reaction cocktail 0.60, Reagent H
0.30, and Reagent I 0.10. Mix by inversion and equilibrate to 37°C. Monitor the
A565 nm until constant, then add: Reagent N 0.02 (blank) and enzyme 0.02 (test),
immediately mix by inversion and incubate at 37°C for exactly 10 min. Then add
Reagent M 2.00 in the both test and blank. Mix by inversion and incubate at 25°C
for exactly 5 min. Transfer to suitable cuvettes and record at 565 nm. For phos-
photransacetylase, continuous spectrophotometric rate determination method was
used. The assay condition was: 25°C, pH= 7.4, 233 nm, and light path= 1 cm.
Reagent A: 100 mM Tris HCl Buffer, pH 7.4 at 25°C, adjust to pH 7.4 at 25°C with
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5M HCl; Reagent B: 100 mM glutathione solution prepare fresh; Reagent C:
6.5 mM coenzyme A solution, prepare fresh; Reagent D: 220 mM acetyl phosphate
solution, prepare fresh; Reagent E: 1 M ammonium sulfate solution; Reagent F: 25
mM Tris HCl Buffer with 500 mM ammonium sulfate, pH 8.0 at 25°C, adjust to pH
8.0 at 25°C with 1M HCl. Procedure: pipette (in ml) the following reagents into
UV cuvettes (test and blank): Reagent A 2.60, Reagent B 0.05, Reagent C 0.20,
Reagent D 0.10, and Reagent E 0.03. Mix by inversion and equilibrate to 25°C.
Moniter A233 nm until constant, then add: Reagent G 0.02 (test) and enzyme 0.02
(blank), immediately mix by inversion and record the increase in A233 nm for
approximately 5 min. Obtain the ΔA233 nmmin−1 using the maximum linear rate
for both the test and blank.
Adaptive laboratory evolution. Adaptive laboratory evolution experiments with
S. cerevisiae sZJD-24 were carried out by serial dilutions in shake ﬂasks. The strains
were cultured at 30°C, 200 r.p.m. in minimal medium with 20 g l−1 glucose. Cells
from three independent colonies were used for three independent evolution series.
Serial transfer was performed every day or every second day. For every transfer, the
cell culture was diluted by a factor ranging from 1:6 to 1:10 into minimal glucose
medium to give an initial OD600 of about 0.1. After 40 days, the three populations
were spread on YPD plates, and three clones were randomly picked from each line
of evolution: sZJD-24-1A, sZJD-24-1B, and sZJD-24-1C from the ﬁrst line, sZJD-
24-2A, sZJD-24-2B, and sZJD-24-2C from the second line, and sZJD-24-3A, sZJD-
24-3B, and sZJD-24-3C from the third line. The speciﬁc growth rates of these nine
strains were determined in shake ﬂasks with 20 g l−1 minimal glucose medium.
Genome sequencing. The genomic DNA of the ALE strains was extracted by
using the Blood & Cell culture DNA Kit. The quality of the genomic DNA was
assessed by the Agilent 2100 Bioanalyzer according to the manufacturer’s
instructions. The genomic DNA of sZJD-24-1C and sZJD-24-2C failed to meet the
sequencing quality requirement and was discarded. DNA from strains ZJD-24-1A,
sZJD-24-1B, sZJD-24-2A, sZJD-24-2B, sZJD-24-3A, sZJD-24-3B, sZJD-24-3C, and
parental strain sZJD-24 was sent for sequencing. The Illumina TruSeq Nano HT 96
was used for preparing libraries for genome sequencing, and whole-genome
sequencing was performed on the Illumina NextSeq by using the 2 × 150 bp paired-
end method according to manufacturer’s manual. S. cerevisiae CEN.PK 113-7D was
used as the reference genome (cenpk.tudelft.nl) for mapping the reads. Breseq-
0.28.1 was used for detecting single nucleotide variants, insertions, and small
deletions37.
Transcriptome analysis. Cells were collected at OD600≈ 1 and stored at −80°C
before processing for RNA extraction. Total RNA was extracted by using the
RNeasy Mini Kit. The quality of RNA samples was assessed by using the Agilent
2100 Bioanalyzer according to the manufacturer’s instructions. The RNA samples
were prepared by using the TruSeq RNA Stranded HT Sample Prep Kit (Illumina)
and sequenced by NextSeq Series Mid-Output Kit (2 × 75) (Illumina). Reads were
aligned on the yeast genome by using Bowtie238 and then further processed by
SAMTools39 and BEDTools40 to count the number of reads aligning to each gene.
Differential gene expression was analyzed by using the DEseq package in the R
programming language41. Reporter analysis on GO terms and transcription factors
was performed by using the Platform for Integrative Analysis of Omics (PIANO) R
package42. Differential expression levels and p-adj values were used as input in
reporter analysis. GO slim mapper analysis was conducted with the online tool at
the SGD website (http://www.yeastgenome.org/cgi-bin/GO/goSlimMapper.pl).
Data availability. The RNA-Seq raw data of the reverse engineered strains and the
control strain can be downloaded from the European Nucleotide Archive with the
access number PRJEB23677 (https://www.ebi.ac.uk/ena/data/search?query=+
PRJEB23677). The data that support the ﬁndings of this study are available within
the article and its Supplementary Information ﬁle or available from the corre-
sponding author upon reasonable request.
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